A132 THREE QUARTERS OF INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE INFLIXIMAB THERAPY IN CLINICAL REMISSION SHOW EVIDENCE OF MUCOSAL INFLAMMATION WITH ELEVATED FECAL CALPROTECTIN

BACKGROUND: Fecal calprotectin (FCP) has been demonstrated to be a noninvasive marker of mucosal inflammation and when elevated, correlates with endoscopic mucosal disease activity in patients with Ulcerative Colitis (UC) and Crohn’s Disease (CD). Endoscopic mucosal healing and normalization of FCP...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Can Assoc Gastroenterol
Main Authors: Stern, N, Wong, K, Dieleman, L A, Halloran, B P, Huang, V, Kroeker, K I, Peerani, F, van Zanten, S, Fedorak, R
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507839/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.133
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados